A. Kiziltunc et al., REDUCED LECITHIN - CHOLESTEROL ACYLTRANSFERASE (LCAT) AND NA-PATIENTS(,K+,ATPASE ACTIVITY IN DIABETIC), Clinical biochemistry, 30(2), 1997, pp. 177-182
Objectives: To investigate the plasma concentrations of lecithin:chole
sterol acyltransferase (LCAT EC 2.3.1.43) and erythrocyte membrane Na,K+,ATPase and the correlation of these parameters in diabetes mellitu
s. Design and Methods: Na+,K+,ATPase was measured with spectro-photome
tric method and LCAT with radioactive method in 19 patients with insul
in-dependent diabetes mellitus (IDDM), in 20 with non-insulin-dependen
t diabetes mellitus (NIDDM) and in 20 healthy volunteers as the contro
l group. Results: Compared with the control group, plasma LCAT concent
rations were found to be decreased in both of the patient groups (p <
0.01 for both). Erythrocyte membrane Na+,K+,ATPase activities were hig
her in the controls than both in the NIDDM and IDDM groups (p < 0.01 a
nd p < 0.001, respectively). There were significant correlations betwe
en LCAT and Na+,K+,ATPase in IDDM (r = 0.82, p < 0.001) and in NIDDM (
r = 0.74, p < 0.001). In order to investigate the effect of cholestero
l (C) and lysophosphatidylcholine (LPC) on Na+,K+,ATPase activity, thi
s enzyme's activity was determined in erythrocyte membranes obtained f
rom diabetic subjects after in vitro incubation with increasing concen
trations of LPC and C (2-10 mu M). Enzymatic activity was significantl
y reduced by in vitro C at increasing concentrations but significantly
increased by in vitro LPC at increasing concentrations. Conclusions:
From these data, it is to be concluded that the decrease in Na+,K+,ATP
ase activity in diabetes might be due to decreased LCAT concentrations
and that may explain the development of atherosclerosis in diabetics.